Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04855253 | Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL | suspended | Phase 1 / Phase 2 | 30 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT03500081 | Solid Tumor Imaging MR-Linac (STIM Study) | suspended | — | 295 | Medical College of WisconsinOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT05351294 |
| Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet |
| suspended |
| Phase 3 |
| 156 |
| Rutgers, The State University of New JerseyOTHER |
| 1 |
| Jan 7, 2026 |
| clinicaltrials |
| NCT06649682 | 68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC(NYCRRLT) | suspended | Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT04840472 | Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer | suspended | Phase 1 | 28 | Stanford UniversityOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT05241210 | Real-Time Feedback (RTFB) to Improve Colonoscopy | suspended | N/A | 4,150 | University of MinnesotaOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07268092 | Porcine Extracellular Matrix Nerve Wrap in Neck Dissection for Head and Neck Cancer | suspended | N/A | 74 | Henry Ford Health SystemOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT05358704 | Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer | suspended | Phase 2 | 38 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05064111 | Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy | suspended | — | 100 | University of ArizonaOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT04392050 | A Community-Based Educational Intervention to Improve Colorectal Cancer Screening | suspended | — | 90 | Thomas Jefferson UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT06709131 | A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia(CT0991) | suspended | Phase 1 | 24 | He HuangOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05844306 | RefleXion PET/CT Imaging Performance in Patients With Various Malignancies | suspended | N/A | 20 | City of Hope Medical CenterOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06454409 | Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia | suspended | Phase 1 | 20 | City of Hope Medical CenterOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07178665 | Pilot Trial of Preop Partial Radiation in Breast Cancer Patients | suspended | Phase 1 | 98 | Rutgers, The State University of New JerseyOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT04657146 | Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma(LAMB-G) | suspended | — | 40 | Duke UniversityOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT05033522 | Immunotherapy for Advanced Liver Cancer(ALIVE) | suspended | Phase 2 / Phase 3 | 150 | Mirror Biologics, Inc.INDUSTRY | 2 | Oct 23, 2025 | clinicaltrials |
| NCT06940570 | Methadone as an Alternative Treatment for Children Underdoing HSCT(MATCH) | suspended | Phase 3 | 60 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 23, 2025 | clinicaltrials |
| NCT03392064 | A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC | suspended | Phase 1 | 6 | AmgenINDUSTRY | 1 | Oct 15, 2025 | clinicaltrials |
| NCT03417921 | A Study of ABTL0812 in Pancreatic Cancer(Pancreatic) | suspended | Phase 1 / Phase 2 | 60 | Ability Pharmaceuticals SLINDUSTRY | 1 | Oct 1, 2025 | clinicaltrials |
| NCT04300335 | The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma | suspended | N/A | 45 | Medical University of ViennaOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT03738267 | Study on the Occurrence of Head and Neck Cancers During Pregnancy(REFCORbirth) | suspended | — | 14 | Centre Francois BaclesseOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT04693546 | Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening(PREVENT) | suspended | — | 12,000 | Metabiomics CorpINDUSTRY | 1 | Sep 26, 2025 | clinicaltrials |
| NCT05445609 | Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer | suspended | Phase 2 | 10 | Emory UniversityOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT02742883 | A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) | suspended | Phase 2 | 1 | Burzynski Research InstituteOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT05820633 | Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.(PCS-XI) | suspended | N/A | 500 | CHU de Quebec-Universite LavalOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06639958 | A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home | suspended | N/A | 64 | Children's Oncology GroupNETWORK | 1 | Aug 29, 2025 | clinicaltrials |
| NCT05591534 | Endorectal Brachytherapy for Rectal Cancer(ICUREC) | suspended | Phase 2 | 31 | University Hospital, BordeauxOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT05958199 | A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7 | suspended | Phase 1 | 131 | NextPoint Therapeutics, Inc.INDUSTRY | 1 | Jun 27, 2025 | clinicaltrials |
| NCT06728657 | Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma(TORCH-G) | suspended | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT05603572 | KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) | suspended | Phase 1 / Phase 2 | 148 | Primocure PharmaINDUSTRY | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05475522 | Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases(SONOFLUO) | suspended | N/A | 134 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT05485038 | General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas(GAMMA) | suspended | N/A | 72 | Sklifosovsky Institute of Emergency CareOTHER_GOV | 1 | May 16, 2025 | clinicaltrials |
| NCT04973930 | Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer(IPT) | suspended | Phase 3 | 20 | New York State Psychiatric InstituteOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT04668365 | Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma | suspended | Phase 2 | 59 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 25, 2025 | clinicaltrials |
| NCT02311712 | Non-endoscopic EC Screening Program in Northern Iran(NESP) | suspended | N/A | 12,000 | Tehran University of Medical SciencesOTHER | 0 | Apr 16, 2025 | clinicaltrials |
| NCT03187210 | Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas(BAL) | suspended | Phase 1 / Phase 2 | 20 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT04339517 | Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer | suspended | N/A | 20 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT05375708 | Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Metastatic Sites(SIRIUS) | suspended | Phase 2 | 93 | UMC UtrechtOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06643494 | Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical | suspended | Phase 1 / Phase 2 | 100 | Optimal Health ResearchOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT04268888 | Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC(TACE-3) | suspended | Phase 2 / Phase 3 | 522 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 2 | Feb 26, 2025 | clinicaltrials |
| NCT05191667 | AN0025 and Chemoradiotherapy Combination in Esophageal Cancer | suspended | Phase 1 | 32 | Adlai Nortye Biopharma Co., Ltd.INDUSTRY | 1 | Feb 13, 2025 | clinicaltrials |
| NCT02935478 | Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation | suspended | N/A | 8 | St. Louis UniversityOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT02355171 | Personalize My Treatment (PMT) Registry(PMT) | suspended | — | 10,000 | Exactis InnovationOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT04151368 | Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy(RNSM) | suspended | N/A | 30 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT04840186 | EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden(EXCALIBUR3) | suspended | Phase 2 | 62 | Oslo University HospitalOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT05076591 | IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors | suspended | Phase 1 | 135 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT06199882 | SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma | suspended | Phase 2 | 34 | Zhejiang Cancer HospitalOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05123534 | A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG | suspended | Phase 2 | 15 | SonALAsense, Inc.INDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT02037529 | Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer | suspended | Phase 3 | 201 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 20, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jan 15, 2026source: clinicaltrials